FDA Greenlights Breakthrough Treatment for Small Cell Lung Cancer
In a significant stride towards battling one of the most aggressive forms of lung cancer, the FDA has recently given its seal of approval to a groundbreaking drug tailored for patients with small cell lung cancer (SCLC). This approval marks a pivotal moment in the fight against this deadly disease, offering hope to the approximately […]